At AstraZeneca UK, we have an incredible project pipeline and an impressive determination to use that pipeline as a means to improve lives, together. With a 8,300-strong team of spirited colleagues from 70 countries across our UK sites, we’re mixing collaboration with entrepreneurship to bring better medicines to people all over the world.
With brand-new development and investment being put into our global scientific research, we’re growing our capabilities as a supplier of life-changing medicine. In the UK, our new strategic, global R&D Centre in Cambridge will allow us to expand our R&D work – now and in the future. And, with 50 different medicines produced in our Macclesfield site, vital biologics work taking place in Speke, marketing for UK, Europe and beyond in Luton, and a variety of functions in our other three sites, this is where you can do what you love, while making a big impact.
Did you know? The completion and full occupation of our R&D Centre at the heart of the Cambridge Biomedical Campus will enable hundreds of scientists and researchers from AstraZeneca to work alongside our partners on cutting-edge research.
Cambridge is one of the most exciting bioscience hotspots in the world. The city is home to our global headquarters and one of AstraZeneca’s three strategic, global R&D Centres, alongside Gothenburg and Gaithersburg, which plays a central role in our mission to deliver life-changing medicines to patients.
For our people at AstraZeneca, Cambridge is the perfect environment for bringing exciting new ideas to the surface. With an open and innovative culture, we work together on a whole range of R&D projects. From exploring molecule combinations to working on clinical development and pre-clinical research assignments, over 3,500 people are exploring a world of specialist capabilities available on site.
The collaboration doesn’t stop at the R&D labs either. Beyond the office, we are committed to providing a vibrant, inclusive and sociable environment where teams and individuals can join in with fun events and activities across campus. We also have a fantastic range of local partnerships whereby employees can gain free entry, benefit from exclusive access and enjoy discounted rates at a selection of leisure attractions.
Macclesfield is a vibrant and successful campus, with 101 acres dedicated to science, technology and manufacturing excellence. As an advanced manufacturing and development campus, Macclesfield has 4,000 talented people covering the widest range of vital roles – it is the biggest pharmaceutical manufacturing site in the UK, the base for our second largest global IT hub and the home of Pharmaceutical Technology, Global Quality and Supply Chain & Strategy teams.
We seamlessly blend scientific knowledge, state-of-the-art technology and advanced manufacturing expertise in a cohesive environment where the energy and pioneering spirit of our people thrives. The potential in our science is amazing. The promise for our patients, enormous. And it’s ensuring our ground-breaking science reaches our patients that unites and inspires everyone. Delivering 72 million packs of medicine to over 130 countries, representing 1% of total UK export for goods.
It is a part of a global interdependent network where we blend science and technology expertise with manufacturing excellence to deliver the medicines that transform lives.
Macclesfield is where science becomes medicine.
Next to the Mersey River and down the road from the cultural hub that is Liverpool city, the AstraZeneca Liverpool site is where biologics comes to life. Here, we bring together research scientists, manufacturing associates, engineers, quality professionals and support personnel in a bid to safeguard public health against seasonal influenza.
The Liverpool site manufactures the drug substance for our intranasal Live Attenuated Influenza Vaccine (LAIV) that supports the UK’s childhood vaccination programme, the USA’s Vaccines for Children (VFC) and Vaccines for Adults (VFA) programs and a number of other vaccination programmes around the world. We work as one agile and collaborative team to deliver a vaccine that targets the flu strains identified for each season.
We have the facilities to research, develop, produce and distribute over 20 million vaccine doses a year for the global market. The work we do has a visible impact on people and the work you do will make a real difference in the fight against both seasonal influenza and the threat of an influenza pandemic.